Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 liquidated — weigh against the wins.
1 vehicle on file, newest listing first
Jeffrey Schwartz is a Partner and Chief Operating Officer for Global Private Equity at Bain Capital, having joined the firm in 2004. He is also a co-founder and Managing Director of Bain Capital Life Sciences. In his current capacity, he oversees global private equity operations, while his prior roles at the firm included serving on the Life Sciences team and the North America Private Equity team, where he focused on healthcare investments. Before joining Bain Capital, Schwartz was an Equity Research Analyst at Lehman Brothers, concentrating on the aerospace and defense industries across both New York and London. He is based in Boston.
Schwartz served as the Chief Executive Officer and a director of BCLS Acquisition Corp. (BLSA), a special purpose acquisition company sponsored by Bain Capital Life Sciences. The SPAC held its IPO on October 22, 2020, raising $143.75 million in proceeds with Goldman Sachs acting as the left lead underwriter. BCLS Acquisition Corp. ultimately liquidated without completing a business combination. In addition to his SPAC leadership, Schwartz serves as a general partner of Bain Capital Life Sciences (BCLSP), where he governs the investment strategy and decision-making process alongside Adam Koppel. He has also been associated with investments in companies such as Rapid Micro Biosystems, Inc.
Schwartz holds an MBA from The Wharton School at the University of Pennsylvania, where he was designated a Palmer Scholar. He also graduated magna cum laude from Yale University with a Bachelor of Arts in economics. His extensive experience in private equity, life sciences, and investment strategy has established him as a key figure within Bain Capital's leadership and the broader healthcare investment community.
This record is keyed to SEC CIK 0001702957 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 43 institutional-holder rows on these vehicles, under 17 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.